Please fill out this form to watch the recording:

Would you like to receive special offers, product updates, and event news from 3D Systems? By clicking "Yes", you agree to receive follow-up email or phone communications from 3D Systems or our partners. You can also choose to opt out of communications at any time. Please click here to view our Privacy Policy or click here to manage your Preferences.



Watch an exclusive webinar showcasing groundbreaking research in orthopaedic implant technology. Discover how 3D-printed porous hydroxyapatite (HA) enhanced PEEK cages are demonstrating promising bone ingrowth results in preclinical studies. 

What You’ll Learn: 

  • Insights and clinical evidence from a recent animal study evaluating osseointegration with porous HA-enhanced PEEK
  • Implications for future clinical applications and device design  
     

Presented by:

William Walsh, Ph.D., Director of the Surgical and Orthopaedic Research Lab (SORL), UNSW, Sydney, Australia 

Stefan Leonhardt, Ph.D., Director of Medical Devices, 3D Systems 

Sean Fenske, Editor-in-Chief, Medical Product Outsourcing and Orthopedic Design & Technology

And to read the companion white paper click here.

Featured Products

PEEK Material

High-performance, biocompatible polymer ideal for medical implants

EXT 220 MED 3D Printer

EXT 220 MED

The only extrusion platform that features an integrated clean room and is validated by leading medical device manufacturers and hospitals worldwide.

Stefan Leonhard

Stefan Leonhardt

Director of Medical Devices

Specialties:Implantable Polymer Materials, Medical Device Development, Additive Manufacturing, Biocompatibility, Point-of-Care Manufacturing

Dr. Stefan Leonhardt is Director of Medical Devices, focused on 3D printing with medical high-performance polymers. Stefan joined us in 2022 through the acquisition of Kumovis, a company he co-founded in 2017 to develop the first 3D printing platform specifically designed for medical device production, now known as 3D Systems’ EXT 200 MED.

Stefan studied medical engineering at the Technical University of Munich and holds an MBA with a focus on digital transformation and new business models. Stefan also earned a Ph.D. for his work on material development for resin-based 3D-printing technologies for the development of bioreactors.

More about Stefan Leonhardt